Nov. 18, 2021 /PRNewswire/
-- Amyris, Inc., (Nasdaq: AMRS), a leading synthetic
biotechnology company accelerating the world to sustainable
consumption through its Lab-to-Market™ operating
platform, today announced that it will host a conference call and
live webcast to discuss its recent financing activity on
Monday, November 22, 2021 beginning
at 6:00 a.m. Pacific Time
(9:00 a.m. Eastern Time),
John Melo, President and Chief
Executive Officer, and Han
Kieftenbeld, Chief Financial Officer, will discuss the
Company's recent strategic financing.
Webcast: please visit http://investors.amyris.com A replay of
the webcast will be archived for 90 days on this site.
Live call: (844) 850-0551 (domestic) or (412) 902-4203
(international). Please ask to join the Amyris, Inc. call.
Amyris (Nasdaq: AMRS) is a leading
synthetic biotechnology company, transitioning the Clean Health
& Beauty and Flavors & Fragrances markets to sustainable
ingredients through fermentation and the company's proprietary
Lab-to-Market™ operating platform. This Amyris
platform leverages state-of-the-art machine learning, robotics and
artificial intelligence, enabling the company to rapidly bring new
innovation to market at commercial scale. Amyris ingredients are
included in over 20,000 products from the world's top brands,
reaching more than 300 million consumers. Amyris also owns and
operates a family of consumer brands that is constantly evolving to
meet the growing demand for sustainable, effective and accessible
Amyris, the Amyris logo and Lab-to-Market are trademarks or
registered trademarks of Amyris, Inc. in the U.S. and/or other
SOURCE Amyris, Inc.